Xianfeng He

Chinese Academy of Sciences

Papers

1

Total Citations

71

H-Index

1

About

Xianfeng He is a leading molecular oncologist whose research centers on the molecular pathology of nasopharyngeal carcinoma (NPC) and the identification of tissue-specific biomarkers. His major contributions include pioneering the use of suppression subtractive hybridization (SSH) combined with cDNA microarray technology to isolate genes uniquely expressed in nasopharyngeal epithelial tissue and to uncover those differentially regulated in NPC. This foundational work, detailed in his highly cited 2003 study (71 citations), provided a critical genomic roadmap for understanding NPC pathogenesis and identifying potential therapeutic targets. By systematically comparing normal and malignant tissues, He’s research has illuminated key molecular drivers of this aggressive cancer, offering new avenues for early detection and treatment. His work remains a cornerstone for subsequent studies in NPC genomics, demonstrating lasting impact through sustained citation by the cancer biology community. He continues to advance the field, contributing to our understanding of epithelial tumorigenesis and the development of targeted strategies against nasopharyngeal carcinoma.

Research Focus

Key Achievements

1
H-Index
1
Papers
71
Total Citations
71
Avg Citations/Paper
🏆 Most Cited Paper
Identification of tissue‐specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray
71 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Chinese Academy of Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago